Ulf Andréasson

24.2k total citations · 10 hit papers
178 papers, 13.7k citations indexed

About

Ulf Andréasson is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Ulf Andréasson has authored 178 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Physiology, 63 papers in Psychiatry and Mental health and 54 papers in Molecular Biology. Recurrent topics in Ulf Andréasson's work include Alzheimer's disease research and treatments (104 papers), Dementia and Cognitive Impairment Research (62 papers) and S100 Proteins and Annexins (17 papers). Ulf Andréasson is often cited by papers focused on Alzheimer's disease research and treatments (104 papers), Dementia and Cognitive Impairment Research (62 papers) and S100 Proteins and Annexins (17 papers). Ulf Andréasson collaborates with scholars based in Sweden, United Kingdom and United States. Ulf Andréasson's co-authors include Henrik Zetterberg, Kaj Blennow, Niklas Mattsson, Erik Portelius, Oskar Hansson, Lennart Minthon, Niklas Norgren, Maria Bjerke, Annika Öhrfelt and Bob Olsson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Ulf Andréasson

168 papers receiving 13.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

2016 1.4k citations Ulf Andréasson, Annika Öhrfelt et al. profile →
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

2017 698 citations Niklas Mattsson, Ulf Andréasson et al. profile →
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

2016 543 citations Jens Kühle, Ulf Andréasson et al. Clinical Chemistry and Laboratory Medicine (CCLM) profile →
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

2019 470 citations Niklas Mattsson, Ulf Andréasson et al. profile →
Plasma tau in Alzheimer disease

2016 378 citations Niklas Mattsson, Henrik Zetterberg et al. Neurology profile →
Blood-based NfL

2017 356 citations Oskar Hansson, Shorena Janelidze et al. Neurology profile →
Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

2015 356 citations Ulf Andréasson, Niklas Norgren et al. profile →
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia

2016 319 citations Jonathan D. Rohrer, Niklas Norgren et al. Neurology profile →
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative

2020 218 citations Thomas K. Karikari, Andréa Lessa Benedet et al. Molecular Psychiatry profile →
Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years

2022 111 citations Ulf Andréasson, Johan Gobom et al. Brain Communications profile →

Peers

Countries citing papers authored by Ulf Andréasson

Since Specialization

Citations

This map shows the geographic impact of Ulf Andréasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Andréasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Andréasson more than expected).

Fields of papers citing papers by Ulf Andréasson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Andréasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Andréasson. The network helps show where Ulf Andréasson may publish in the future.

Co-authorship network of co-authors of Ulf Andréasson

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Andréasson. A scholar is included among the top collaborators of Ulf Andréasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Andréasson. Ulf Andréasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds 2025 ·Alzheimer s Research & Therapy ·Silke Kern, Tobias Skillbäck, (unknown), (unknown), Felicia Ahlner, Anna Zettergren, Margda Wærn, Nazib M. Seidu, Ulf Andréasson, Kaj Blennow, Ingmar Skoog	0
2	Novel insights into the molecular nature of neurofilament light polypeptide species in cerebrospinal fluid 2025 ·Brain Communications ·Bruno Becker, Johan Gobom, Gunnar Brinkmalm, Ulf Andréasson, Francisco J. Meda, Henrik Zetterberg, Kaj Blennow	1
3	Plasma levels of the neuron damage markers brain-derived tau and glial fibrillary acidic protein in Lyme neuroborreliosis: A longitudinal study 2025 ·Ticks and Tick-borne Diseases ·(unknown), Fernando González‐Ortiz, (unknown), Åse Bengård Andersen, (unknown), Ulf Andréasson, Kaj Blennow, Helene Mens, Henrik Zetterberg, Anne‐Mette Lebech	0
4	Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood 2023 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Ulf Andréasson, Johan Gobom, Vincent Delatour, (unknown), Yoav Noam, Stephen Lee, (unknown), Andreas Jeromin, Burak Arslan, Aleksandra Maleska Maceski, Eline A.J. Willemse, Henrik Zetterberg, Jens Kühle, Kaj Blennow	21
5	Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample 2023 ·Alzheimer s Research & Therapy ·(unknown), Ingmar Skoog, Tobias Skillbäck, Henrik Zetterberg, Jürgen Kern, Anna Zettergren, Ulf Andréasson, Hanna Wetterberg, Silke Kern, Kaj Blennow	7
6	α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders 2023 ·Parkinsonism & Related Disorders ·Bárbara Fernandes Gomes, Carly M. Farris, Yihua Ma, Luis Concha‐Marambio, (unknown), Bengt Nellgård, (unknown), (unknown), Radu Constantinescu, Johan Gobom, Ulf Andréasson, Henrik Zetterberg, Kaj Blennow	48
7	Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid 2023 ·BMJ Neurology Open ·Francisco J. Meda, (unknown), Imogen J. Swift, Aitana Sogorb‐Esteve, Jonathan D. Rohrer, (unknown), Ingmar Skoog, Silke Kern, Bruno Becker, Kaj Blennow, Ulf Andréasson, Hlin Kvartsberg, Henrik Zetterberg	11
8	Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative breakdown → 2020 ·Molecular Psychiatry ·Thomas K. Karikari, Andréa Lessa Benedet, Nicholas J. Ashton, Juan Lantero‐Rodriguez, Anniina Snellman, Marc Suárez‐Calvet, Paramita Saha‐Chaudhuri, Firoza Z Lussier, Hlin Kvartsberg, Alexis Moscoso, Tharick A. Pascoal, Ulf Andréasson, Michael Schöll, Michael W. Weiner, Pedro Rosa‐Neto, John Q. Trojanowski, Leslie M. Shaw, Kaj Blennow, Henrik Zetterberg, (unknown)	218
9	Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg 2020 ·Alzheimer s Research & Therapy ·(unknown), Ayesha Khatun, (unknown), Konstantin Senkevich, Jörg Hanrieder, Federica Capraro, Niklas Mattsson, Ulf Andréasson, Erik Portelius, Nicholas J. Ashton, Kaj Blennow, Michael Schöll, Ross W. Paterson, Jonathan M. Schott, Henrik Zetterberg	35
10	Nordic leadership 2018 ·Nordic Council of Ministers eBooks ·Ulf Andréasson, (unknown)	4
11	Blood-based NfL breakdown → 2017 ·Neurology ·Oskar Hansson, Shorena Janelidze, Sara Hall, Nadia Magdalinou, Andrew J. Lees, Ulf Andréasson, Niklas Norgren, Jan Linder, Lars Forsgren, Radu Constantinescu, Henrik Zetterberg, Kaj Blennow, (unknown)	356
12	No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF 2016 ·Molecular Neurodegeneration ·Claudia Cicognola, Davide Chiasserini, Paolo Eusebi, Ulf Andréasson, Hugo Vanderstichele, Henrik Zetterberg, Lucilla Parnetti, Kaj Blennow	15
13	Serum neurofilament light protein predicts clinical outcome in traumatic brain injury 2016 ·Scientific Reports ·Pashtun Shahim, Magnus Gren, Victor Liman, Ulf Andréasson, Niklas Norgren, Yelverton Tegner, Niklas Mattsson, Niels Andreasen, Martin Öst, Henrik Zetterberg, Bengt Nellgård, Kaj Blennow	276
14	Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease 2016 ·Dementia and Geriatric Cognitive Disorders Extra ·Annika Öhrfelt, Per Johansson, Anders Wallin, Ulf Andréasson, Henrik Zetterberg, Kaj Blennow, Johan Svensson	37
15	Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease 2015 ·Alzheimer s Research & Therapy ·(unknown), Hlin Kvartsberg, Erik Portelius, Ulf Andréasson, Timo Jan Oberstein, Piotr Lewczuk, Kaj Blennow, Johannes Kornhuber, Juan Manuel Maler, Henrik Zetterberg, Philipp Spitzer	109
16	Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β‐amyloid (1–42) in human cerebrospinal fluid 2015 ·Alzheimer s & Dementia ·Tobias Bittner, Henrik Zetterberg, Charlotte E. Teunissen, Richard E. Ostlund, (unknown), Ulf Andréasson, Isabelle Hubeek, David W. Gibson, (unknown), Udo Eichenlaub, Peter Heiß, Uwe Kobold, Andreas Leinenbach, Kairat Madin, Ekaterina Manuilova, Christina Rabe, Kaj Blennow	241
17	Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease 2015 ·Brain ·Erik Portelius, Henrik Zetterberg, Tobias Skillbäck, Ulrika Törnqvist, Ulf Andréasson, John Q. Trojanowski, Michael W. Weiner, Leslie M. Shaw, Niklas Mattsson	201
18	Multiplexing and multivariate analysis in neurodegeneration 2012 ·Methods ·Ulf Andréasson, Erik Portelius, Josef Pannee, Henrik Zetterberg, Kaj Blennow	11
19	Cerebrospinal Fluid Profiles of Amyloid β-Related Biomarkers in Alzheimer’s Disease 2012 ·NeuroMolecular Medicine ·Christoffer Rosén, Ulf Andréasson, Niklas Mattsson, Jan Marcusson, Lennart Minthon, Niels Andreasen, Kaj Blennow, Henrik Zetterberg	55
20	Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease 2011 ·Dementia and Geriatric Cognitive Disorders Extra ·Annika Öhrfelt, Ulf Andréasson, Adam J. Simon, Henrik Zetterberg, Åke Edman, William Z. Potter, Daniel Holder, Viswanath Devanarayan, Jeffrey L. Seeburger, A. David Smith, Kaj Blennow, Anders Wallin	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact